Best Pharma Stocks List – Top 6 Pharma Stocks To Buy Now
The pharmaceutical market is considered one of the most stable and risk-resistant sectors, considering the unsatisfied demand in all situations. Pharmaceutical stocks have performed well amid recent stock market turmoil due to inflation, rising interest rates and geopolitical tensions. According to Globalnewswire, this industry is expected to grow from USD 1.454 billion in 2021 to USD 2.135 billion in 2026 at a CAGR of 7.7%. With these statistics and the defensive nature of pharmaceutical stocks, now may be the time to diversify your portfolio with some of the best pharmaceutical stocks.
Here, we've rounded up some of the top performing pharmaceutical stocks.
1. ABV:
AbbVie Inc. is headquartered in North Chicago. It is a leading biopharmaceutical company that manufactures and distributes a range of medicines worldwide. The immunotherapy drug HUMIRA is among the best-selling drugs, along with SKYRIZI, which treats psoriasis, and RINVOQ, which treats severely active rheumatoid arthritis. AbbVie's portfolio includes other popular drugs and therapies such as VENCLEXTA to suppress lymphocytic cancers, CREON for pancreatic enzyme therapy, DUOPA to treat Parkinson's disease and many others.
ABBV is one of the best pharma stocks of 2022 thanks to its strong performance over the past year amid Wall Street's downturn. It currently has a market capitalization of approximately 252 billion and 1.7 billion shares outstanding. Furthermore, AbbVie records a P/E and P/S ratio of 20.23 and 4.43, respectively.
The company is in the Dividend Aristocrats category, which includes all companies that have increased their dividends for 25 consecutive years. Its annual dividend yield is currently 3.94%.
2. Bristol Myers Squibb (BMS)
Bristol Myers Squibb is a New York-based company that manufactures, licenses and distributes pharmaceutical products worldwide. The company's four main products are Eliquis, an anticoagulant, Revlimid, an oral immunosuppressant; Orencia - a drug for the treatment of active rheumatoid arthritis and psoriatic arthritis; And Opdivo, an anti-cancer drug. In addition, the company is developing a number of drugs for oncological, cardiovascular, hematological, fibrotic, neurological, immunological and Covid-19 diseases.
With a market capitalization of 150 billion and solid performance over the past year, BMS is also among the top pharmaceutical stocks. The company has a turnover of 77 billion (ttm) with a price/earnings ratio of 23.4. Moreover, it is a dividend paying stock with a future dividend yield of 3.05% according to the latest data.
3. Eli Lilly & Company (LLI)
Founded in 1876, Eli Lilly is a leading pharmaceutical company specializing in human pharmaceutical products. It makes Humalog, Humulin and various versions of insulin, as well as type 1 and type 2 diabetes drugs Jardiance, Tagenta and Trullity. In addition, Boehringer works with a number of industry leaders such as Ingelheim Pharmaceuticals Inc, AbCellera Biologics Inc and Regor Therapeutics Group. .
Eli Lilly has a total market capitalization of approximately $295 billion with 950 million shares outstanding. The company recorded a profit margin of 49% and a profit margin of 1.26%.
Eli Lilly is among the top pharmaceutical stocks after rising more than 37% last year when most Wall Street stocks tumbled.
4. Pfizer Inc. (PFE)
New York-based Pfizer Inc. manufactures, markets and sells major pharmaceutical products worldwide. It offers cardiovascular and women's health products, immunotherapies, biosimilars, anti-infectives and oral Covid-19 treatments under various brand names. Pfizer gained a lot of fame thanks to the Covid-19 vaccine developed by BioEntech. The vaccine was the first to receive US Food and Drug Administration (FDA) approval for routine use during the outbreak.
Pfizer is considered one of the best pharmaceutical companies because of its generous dividend payouts and consistent revenue streams. The company has a total market capitalization of $247 billion and more than 5.5 billion shares are outstanding. Its most recent earnings report shows $101 billion in revenue over the last 12 months, and 46.80% quarterly revenue growth.
Pfizer has been offering investors quarterly dividends for over 83 years, and the dividend yield is currently 3.63%.
5. Gilead Sciences Inc. (DORER)
Gilead Sciences Inc. is a California-based biopharmaceutical company that researches, develops and markets a variety of therapeutic agents around the world. The company manufactures pharmaceutical products for the treatment of HIV/AIDS, Corona virus, liver diseases, blood and cell pathologies, brain, pulmonary hypertension and fungal diseases. Gilead regularly collaborates with a number of other pharmaceutical companies, including Bristol-Myers Squibb, Arcus Biosciences, Tizona Therapeutics, Jow Therapeutics and Janssen Sciences.
GILD is another key component of big pharma stocks due to rising sales of HIV and oncology drugs. The company has a trailing 12-month return on assets of 10.6% and a p/e ratio of 19.22. Furthermore, the current market capitalization is around 79 billion with 1.25 billion shares.
Gilead pays dividends to shareholders with a current annual dividend yield of 4.65%.
6. Amgen Inc. (AMGN)
California-based Amgen Inc. manufactures and distributes human pharmaceutical products worldwide. It includes a wide range of drugs that treat cardiovascular disease, anemia or blood disorders, arthritis, inflammation, kidney disease, neurological and bone disorders. The drugs manufactured are Enbrel, Neulasta, Prolia, Amjevita and Caprolis. Amgen works with several pharmaceutical companies, including BeiGene Ltd, Eli Lilly and Company, Kyowa Kirin Co Ltd and Datos Health.
AMGN is one of the few stocks on Wall Street that has performed relatively well over the last few difficult months. With a trailing 12-month operating margin of 37% and a return on equity of 123%, it holds a strong position among the top pharmaceutical stocks. The capitalization of the company is 121 billion 534 million shares.
In addition, Amgen Inc. is known for its dividend payouts and catalogs offering an annual dividend yield of 3.42% with a payout ratio of 62.9%.
Read more:
https://thetradingbay.com/top-5-semiconductor-stocks-to-buy-now/
https://thetradingbay.com/best-dividend-stocks-top-8-dividend-stocks-to-buy-now/